David Low
Stock Analyst at UBS
(2.76)
# 2,718
Out of 4,361 analysts
284
Total ratings
47.7%
Success rate
2%
Average return
Main Sectors:
Stocks Rated by David Low
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ASX: RHC Ramsay Health Care Limited | Maintained: Hold | $42.90 | $36.30 | +18.18% | 20 | May 28, 2026 | |
| ASX: CSL CSL Limited | Maintained: Buy | $205.00 → $175.00 | $92.12 | +89.97% | 26 | May 12, 2026 | |
| ASX: COH Cochlear Limited | Downgraded: Hold | n/a | $95.49 | - | 18 | May 1, 2026 | |
| ASX: RMD ResMed Inc. | Maintained: Buy | n/a | $25.74 | - | 24 | Apr 28, 2026 | |
| ASX: SHL Sonic Healthcare Limited | Maintained: Hold | $21.80 → $21.10 | $18.78 | +12.35% | 30 | Mar 15, 2026 | |
| ASX: ANN Ansell Limited | Maintained: Hold | $36.00 → $35.60 | $27.53 | +29.31% | 15 | Feb 16, 2026 | |
| ASX: TLX Telix Pharmaceuticals Limited | Downgraded: Hold | $16.50 | $12.24 | +34.86% | 3 | Aug 31, 2025 | |
| ASX: PNV PolyNovo Limited | Maintained: Hold | $1.30 | $1.06 | +22.64% | 1 | Aug 27, 2025 | |
| NZE: EBO EBOS Group Limited | Maintained: Hold | $46.34 → $43.93 | $19.22 | +128.59% | 3 | Aug 27, 2025 | |
| ASX: NAN Nanosonics Limited | Maintained: Sell | $4.00 → $3.90 | $3.15 | +23.81% | 20 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $3.25 → $3.40 | $2.06 | +65.45% | 12 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Sell | $0.62 | $0.322 | +92.55% | 26 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7.10 → $8.00 | $6.18 | +29.45% | 13 | Aug 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $282.00 → $300.00 | $161.10 | +86.23% | 5 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $290 → $310 | $182.82 | +69.57% | 43 | Aug 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | 32.00 → 35.00 | $36.77 | n/a | 13 | Jun 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $0.95 → $0.78 | $0.32 | n/a | 4 | Mar 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $13.49 | n/a | 7 | Aug 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $16.63 | n/a | 1 | Dec 4, 2019 |
Ramsay Health Care Limited
May 28, 2026
Maintained: Hold
Price Target: $42.90
Current: $36.30
Upside: +18.18%
CSL Limited
May 12, 2026
Maintained: Buy
Price Target: $205.00 → $175.00
Current: $92.12
Upside: +89.97%
Cochlear Limited
May 1, 2026
Downgraded: Hold
Price Target: n/a
Current: $95.49
Upside: -
ResMed Inc.
Apr 28, 2026
Maintained: Buy
Price Target: n/a
Current: $25.74
Upside: -
Sonic Healthcare Limited
Mar 15, 2026
Maintained: Hold
Price Target: $21.80 → $21.10
Current: $18.78
Upside: +12.35%
Ansell Limited
Feb 16, 2026
Maintained: Hold
Price Target: $36.00 → $35.60
Current: $27.53
Upside: +29.31%
Telix Pharmaceuticals Limited
Aug 31, 2025
Downgraded: Hold
Price Target: $16.50
Current: $12.24
Upside: +34.86%
PolyNovo Limited
Aug 27, 2025
Maintained: Hold
Price Target: $1.30
Current: $1.06
Upside: +22.64%
EBOS Group Limited
Aug 27, 2025
Maintained: Hold
Price Target: $46.34 → $43.93
Current: $19.22
Upside: +128.59%
Nanosonics Limited
Aug 27, 2025
Maintained: Sell
Price Target: $4.00 → $3.90
Current: $3.15
Upside: +23.81%
Aug 27, 2025
Maintained: Buy
Price Target: $3.25 → $3.40
Current: $2.06
Upside: +65.45%
Aug 25, 2025
Maintained: Sell
Price Target: $0.62
Current: $0.322
Upside: +92.55%
Aug 18, 2025
Downgraded: Hold
Price Target: $7.10 → $8.00
Current: $6.18
Upside: +29.45%
Aug 14, 2025
Maintained: Hold
Price Target: $282.00 → $300.00
Current: $161.10
Upside: +86.23%
Aug 1, 2025
Maintained: Buy
Price Target: $290 → $310
Current: $182.82
Upside: +69.57%
Jun 3, 2025
Maintained: Hold
Price Target: 32.00 → 35.00
Current: $36.77
Upside: n/a
Mar 2, 2025
Maintained: Buy
Price Target: $0.95 → $0.78
Current: $0.32
Upside: n/a
Aug 23, 2021
Maintained: Hold
Price Target: n/a
Current: $13.49
Upside: n/a
Dec 4, 2019
Downgraded: Hold
Price Target: n/a
Current: $16.63
Upside: n/a